Highlights

  • CTQ’s strategic investor Antanas Guoga converted 355,678 unquoted convertible notes into 35,567,808 fully paid ordinary shares.
  • The conversion was completed at a conversion price of AUD 0.01 per share.
  • Following the transaction, Careteq has no convertible notes on issue and no drawn Debt facilities.
  • Management said the conversion reflects continued support for the company’s strategic direction and growth initiatives.
  • The company remains focused on expanding its HMR Referrals platform and broader AI-enabled healthcare solutions.

Careteq Limited (ASX:CTQ) has announced that strategic investor Antanas Guoga, widely known as Tony G, has elected to convert his holding of unquoted convertible notes into ordinary shares, a move that leaves the healthcare technology company with a simplified Capital Structure and no convertible notes outstanding.

The update marks a notable development for Careteq as it continues to focus on the commercialisation of its healthcare technology offerings. The company stated that the conversion reflects ongoing support from a long-term strategic investor and further aligns Shareholder interests as Careteq pursues growth opportunities across its AI-enabled healthcare platforms.

On 4 June 2026, Careteq shares traded at AUD 0.013, unchanged for the day. Over the past 12 months, however, the stock has gained 30.00%, reflecting a period during which the company has continued developing its healthcare technology platform and commercial initiatives.

Careteq operates within the clinical health technology sector and focuses on delivering digital and AI-enabled healthcare solutions. The company's primary platform, HMR Referrals, is designed to streamline the Home Medicines Review process and improve efficiency across healthcare delivery pathways. Management's broader strategy centres on leveraging technology to support improved healthcare outcomes while expanding commercial opportunities across the healthcare ecosystem.

Strategic Investor Converts Notes into More Than 35 Million Shares

At the centre of the announcement was the conversion of 355,678 unquoted convertible notes held by Antanas Guoga into 35,567,808 fully paid ordinary shares.

The conversion was completed at a price of AUD 0.01 per share.

Rather than redeeming the convertible notes, Mr Guoga chose to convert his Investment into Equity, increasing his direct exposure to the company's future performance. According to Careteq, the decision demonstrates confidence in the company's strategic direction and its long-term opportunities within the health technology sector.

The transaction also removes a layer of complexity from the company's Balance Sheet by eliminating the remaining convertible note obligations.

Convertible notes often provide investors with the option to convert debt-like instruments into equity under specified conditions. Following the completion of this conversion, Careteq confirmed that no convertible notes remain on issue.

Management highlighted the importance of this outcome as part of its broader capital management strategy.

Capital Structure Simplified Following Conversion

One of the key outcomes from the transaction is the simplification of Careteq's capital structure.

The company stated that it now has no convertible notes outstanding and no drawn debt facilities.

For listed companies, reducing debt-related obligations and removing convertible securities can provide greater transparency regarding future capital structures and shareholder ownership. It can also reduce uncertainty associated with potential future conversions.

Careteq indicated that the completion of the conversion provides a cleaner balance sheet position as it continues pursuing growth initiatives.

The company views this simplified structure as supportive of its ongoing commercialisation efforts and broader corporate objectives.

With no outstanding convertible notes and no debt facilities currently drawn, management believes the company is better positioned to focus on operational execution and Business development activities.

Investor Support Seen as Vote of Confidence

The company placed considerable emphasis on the significance of support from Antanas Guoga.

Mr Guoga is a former Member of the European Parliament and has built a reputation as a technology investor and Entrepreneur through investments across various technology and innovation-focused businesses.

Careteq described him as one of Europe's more prominent technology investors with a history of backing companies pursuing innovation-led growth opportunities.

According to the company, the decision to convert rather than redeem the notes demonstrates continued confidence in Careteq's strategy and future direction.

By converting into ordinary shares, the investor's interests become directly aligned with those of other shareholders, linking future returns more closely to the company's operational and commercial performance.

Management highlighted this alignment as an important aspect of the transaction.

The conversion effectively shifts the relationship from creditor to equity investor, reinforcing long-term participation in the company's growth initiatives.

Focus Remains on AI-Enabled Healthcare Solutions

While the announcement primarily focused on the convertible note conversion, Careteq also reiterated its commitment to expanding its healthcare technology operations.

The company continues to develop and commercialise AI-enabled healthcare solutions aimed at improving healthcare delivery and patient outcomes.

A key part of this strategy is HMR Referrals, Careteq's wholly owned marketplace platform.

The platform is designed to streamline the process associated with Home Medicines Reviews, helping healthcare providers manage referrals and workflow requirements more efficiently.

Home Medicines Reviews play an important role in supporting medication management, particularly for patients requiring detailed medication assessments.

By digitising and simplifying referral pathways, Careteq aims to improve operational efficiency while supporting better healthcare outcomes.

Management indicated that the company remains focused on growing adoption of the platform while continuing to expand its broader health technology offering.

Health Technology Sector Continues to Embrace Digital Transformation

Careteq's strategy is positioned around ongoing digital transformation within healthcare.

Healthcare providers, clinicians and patients are increasingly adopting technology-based solutions designed to improve accessibility, efficiency and decision-making.

The use of artificial intelligence and digital platforms has become an area of growing interest across healthcare systems globally as organisations seek to enhance service delivery and reduce administrative burdens.

Careteq's focus on AI-enabled healthcare solutions aligns with these broader industry trends.

Through HMR Referrals and related initiatives, the company is seeking to establish a stronger presence within the healthcare technology landscape.

The latest capital structure update may provide additional flexibility as management continues to pursue commercial opportunities and platform expansion initiatives.

Debt-Free Position Supports Operational Focus

Another notable aspect of the announcement is the company's confirmation that it has no drawn debt facilities.

A debt-free operating position can provide companies with greater flexibility when allocating resources toward product development, customer Acquisition, platform enhancement and commercial execution.

Careteq stated that following the conversion, it can maintain focus on expanding its commercial activities without the complexity associated with outstanding convertible instruments or drawn debt obligations.

The company believes this positions it favourably as it continues advancing its health technology strategy.

While the announcement did not include financial guidance or operational performance metrics, management emphasised that the simplified capital structure supports the next phase of the company's growth objectives.

What This Means for Investors

Careteq's latest announcement centres on capital structure simplification and increased alignment between the company and a strategic investor.

The conversion of 355,678 convertible notes into 35,567,808 ordinary shares removes all outstanding convertible notes and leaves the company with no drawn debt facilities.

Management views the transaction as a reflection of confidence from a prominent technology investor while also creating a cleaner corporate structure.

Although the update did not contain Revenue, Earnings or operational performance figures, it highlighted several factors that investors often monitor closely, including shareholder alignment, capital structure clarity and financial flexibility.

Going forward, market attention is likely to remain focused on the commercial progress of Careteq's HMR Referrals platform and its broader AI-enabled healthcare initiatives as the company continues pursuing growth opportunities within the healthcare technology sector.